Mar 26, 2026SGLT2 Inhibitors Protect Kidneys Beyond DiabetesSGLT2 inhibitors cut CKD progression by 37% in major trials, including people without diabetes. What the evidence supports—and what remains uncertain.sglt2 inhibitorskidney diseaserenal protectionRead article →